Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 7,136 $ 12,162
Trading marketable securities 10,859 11,951
Available-for-sale securities (amortized cost of $1,524 and $0, respectively) 1,488 0
Prepaid expenses and other current assets 686 496
Deferred offering costs 134 0
Total Current Assets 20,303 24,609
Intangible asset 2,039 2,039
Available-for-sale securities (amortized cost of $0 and $1,524, respectively) 0 1,519
Operating lease right-of-use assets 70 81
Other assets 3 3
TOTAL ASSETS 22,415 28,251
Current Liabilities    
Accounts payable and accrued liabilities 411 975
Due to related parties 27 21
Operating lease liabilities - current portion 42 31
Total Current Liabilities 480 1,027
Operating lease liabilities 32 57
TOTAL LIABILITIES 512 1,084
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized, 0 shares issued and outstanding 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized, 2,855,688 and 2,820,068 shares issued and outstanding, respectively 3 3
Additional paid-in capital 49,970 48,120
Accumulated deficit (27,682) (20,938)
Accumulated other comprehensive loss (388) (18)
Total Stockholders' Equity 21,903 27,167
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 22,415 $ 28,251